Literature DB >> 15237233

Genetic modifiers in mice: the example of the fragile X mouse model.

V Errijgers1, R F Kooy.   

Abstract

Modifiers play an important role in most, if not all human diseases, and mouse models. For some disease models, such as the cystic fibrosis knockout mouse model, the effect of genetic factors other than the causative mutation has been well established and a modifier gene has been mapped. For other mouse models, including those of the fragile X syndrome, a common form of inherited mental retardation, controversies between test results obtained in different laboratories have been well recognized. Yet, the possibility that modifiers could at least explain part of the discrepancies is only scarcely mentioned. In this review we compare the test results obtained in different laboratories and provide evidence that modifiers may affect disease severity in the fragile X knockout mouse. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 15237233     DOI: 10.1159/000078218

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  6 in total

1.  Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice.

Authors:  Aimee V Franklin; Margaret K King; Valle Palomo; Ana Martinez; Lori L McMahon; Richard S Jope
Journal:  Biol Psychiatry       Date:  2013-09-13       Impact factor: 13.382

2.  Synaptic ionotropic glutamate receptors and plasticity are developmentally altered in the CA1 field of Fmr1 knockout mice.

Authors:  Yair Pilpel; Aleksander Kolleker; Sven Berberich; Melanie Ginger; Andreas Frick; Edwin Mientjes; Ben A Oostra; Peter H Seeburg
Journal:  J Physiol       Date:  2008-12-22       Impact factor: 5.182

3.  Disruption of Foxg1 expression by knock-in of cre recombinase: effects on the development of the mouse telencephalon.

Authors:  K L Eagleson; L J Schlueter McFadyen-Ketchum; E T Ahrens; P H Mills; M D Does; J Nickols; P Levitt
Journal:  Neuroscience       Date:  2007-07-19       Impact factor: 3.590

Review 4.  Turning strains into strengths for understanding psychiatric disorders.

Authors:  Shannon J Moore; Geoffrey G Murphy; Victor A Cazares
Journal:  Mol Psychiatry       Date:  2020-05-13       Impact factor: 15.992

5.  Positron Emission Tomography (PET) Quantification of GABAA Receptors in the Brain of Fragile X Patients.

Authors:  Charlotte D'Hulst; Inge Heulens; Nathalie Van der Aa; Karolien Goffin; Michel Koole; Kathleen Porke; Marc Van De Velde; Liesbeth Rooms; Wim Van Paesschen; Hilde Van Esch; Koen Van Laere; R Frank Kooy
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

6.  Utility of the Hebb-Williams Maze Paradigm for Translational Research in Fragile X Syndrome: A Direct Comparison of Mice and Humans.

Authors:  Isabelle Boutet; Charles A Collin; Lindsey S MacLeod; Claude Messier; Matthew R Holahan; Elizabeth Berry-Kravis; Reno M Gandhi; Cary S Kogan
Journal:  Front Mol Neurosci       Date:  2018-03-28       Impact factor: 5.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.